Trending Stock News

Cedar Realty Trust Inc (NYSE:CDR) Short Interest Rose By 7.58%

Cedar Realty Trust Inc (NYSE:CDR) Short Interest Rose By 7.58%

During 2018 Q4 the big money sentiment increased to 1.57. That’s change of 0.18, from 2018Q3’s 1.39. 8 investors sold all, 41 reduced holdings as Cedar Realty Trust, Inc. ratio increased. 49 grew positions while 28 funds bought positions. Funds hold 77.63 million shares thus 2.09% less from 2018Q3’s 79.29 […]

Flaherty & Crumrine Dynamic Preferred & Income Fund Inc (NYSE:DFP) Stock Price Up as Sentiment Worsens, now at 1.12

Positions for Flaherty & Crumrine Dynamic Preferred & Income Fund Inc (NYSE:DFP) “Big money sentiment for Flaherty & Crumrine Dynamic Preferred & Income Fund Inc (NYSE:DFP) in 2018 Q4 decreased to 1.12, SEC filings reveal. So its down -0.41, from 2018Q3’s 1.53. 19 hedge funds increased and started new equity […]

As of Mar 22, 2019 Caredx Inc (NASDAQ:CDNA) Sellers Decreased Their Shorts By 0.92%

As of Mar 22, 2019 Caredx Inc (NASDAQ:CDNA) Sellers Decreased Their Shorts By 0.92%

Big Money Sentiment decreased to 2.02 in Q4 2018. It has change of 0.16, from 2018Q3’s 2.18. The ratio dived due to CareDx, Inc positioning: 13 sold and 29 reduced. 36 funds bought stakes and 49 increased stakes. Investors holded 28.20 million in 2018Q3 but now own 34.23 million shares […]

Cardlytics Inc (NASDAQ:CDLX) Sellers Rose By 2.93% Their Shorts

Cardlytics Inc (NASDAQ:CDLX) Sellers Rose By 2.93% Their Shorts

It was reported an increase on Cardlytics Inc (NASDAQ:CDLX)’s shorted shares with 2.93%. FINRA announced in March CDLX’s total 1.71 million shorted shares. The 1.66M previous shares are up with 2.93%. With Average volume 105,500, CDLX’s previous position will take 16 days to restore. Float short on Cardlytics Inc is […]

Big Money  Positive on Atara Biotherapeutics (NASDAQ:ATRA), Sentiment at 1.43

Big Money Positive on Atara Biotherapeutics (NASDAQ:ATRA), Sentiment at 1.43

Positions for Atara Biotherapeutics (NASDAQ:ATRA) “Big money sentiment for Atara Biotherapeutics (NASDAQ:ATRA) in Q4 2018 increased to 1.43, SEC filings reveal. That’s up 0.36, from 2018Q3’s 1.07. 57 investment managers increased or started new positions, while 40 sold and reduced holdings in Atara Biotherapeutics so the sentiment is better. Funds […]